Literature DB >> 7052339

Atropine inhibits thromboxane A2 generation in isolated lungs of the guinea-pig.

F Berti, G C Folco, A Giachetti, S Malandrino, C Omini, T Viganò.   

Abstract

1 Histamine (0.5 to 5 micrograms) and slow reacting substance of anaphylaxis (SRS-A, 0.05 to 0.3 u), injected in the isolated, perfused lungs of normal and ovalbumin-sensitized guinea-pigs, promote formation and release of thromboxane A2(TXA2) and other arachidonate metabolites, the effect being more pronounced in sensitized lungs. 2 Carbachol injected (1 to 10 micrograms) or perfused (1 micrograms ml-1 min-1) through normal or sensitized lungs does not elicit formation of TXA2 and prostaglandins. Furthermore the increased generation of arachidonate metabolites due to histamine is not altered by carbachol. 3 Atropine and ipratropium bromide (1 microgram ml-1 min-1) reduce significantly the increased rate of production of TXA2 caused by histamine and SRS-A both in normal and sensitized lungs, whereas hexamethonium (10 to 25 micrograms ml-1 min-1) is ineffective. 4 The mechanism of action of atropine in inhibiting the increased generation of TXA2 is clearly not related to its antimuscarinic or antihistaminic properties. The drug might act at the early events, involved in the activation of arachidonic acid metabolism. The results suggest new sites of action for atropine which, besides the control of the vagal bronchomotor tone, interferes directly with the primary mediators of anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7052339      PMCID: PMC2044192          DOI: 10.1111/j.1476-5381.1980.tb14560.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  Interaction between the release of SRS-A and of prostaglandins [proceedings].

Authors:  D M Engineer; P J Piper; P Sirois
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

3.  Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung.

Authors:  W Dawson; J R Boot; A F Cockerill; D N Mallen; D J Osborne
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

4.  The physicochemical characteristics and purification of slow-reacting substance of anaphylaxis.

Authors:  R P Orange; R C Murphy; M L Karnovsky; K F Austen
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

5.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

6.  Inhibition of antigen-induced bronchoconstriction by atropine in asthmatic patients.

Authors:  D Y Yu; S P Galant; W M Gold
Journal:  J Appl Physiol       Date:  1972-06       Impact factor: 3.531

7.  Role of vagus nerves in experimental asthma in allergic dogs.

Authors:  W M Gold; G F Kessler; D Y Yu
Journal:  J Appl Physiol       Date:  1972-12       Impact factor: 3.531

8.  Prostaglandins released by the spleen.

Authors:  N Gilmore; J R Vane; J H Wyllie
Journal:  Nature       Date:  1968-06-22       Impact factor: 49.962

9.  A method for measuring the unstable thromboxane A2: radioimmunoassay of the derived mono-O-methyl-thromboxane B2.

Authors:  E Granström; H Kindahl; B Samuelsson
Journal:  Prostaglandins       Date:  1976-12

10.  The release of prostaglandins and thromboxanes from guinea-pig lung by slow reacting substance of anaphylaxis, and its inhibition.

Authors:  D M Engineer; H R Morris; P J Piper; P Sirois
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

View more
  7 in total

1.  Effect of muscarinic receptor stimulation on release of cysteinyl-leukotrienes and thromboxane B2 from anaphylactic guinea-pig hearts.

Authors:  G Wittmann; P Weinerowski; T Simmet; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

2.  Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs.

Authors:  E Vannier; J Lefort; A Lellouch-Tubiana; B Terlain; B B Vargaftig
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Pharmacologic characterization of immune complex induced bronchoconstriction in guinea pigs.

Authors:  Z E Mielens; E W Ferguson; R A Ferrari
Journal:  Agents Actions       Date:  1981-12

4.  Leukotriene D4 potentiates histamine-induced bronchoconstriction in guinea-pigs.

Authors:  A G Stewart; D C Thompson; M R Fennessy
Journal:  Agents Actions       Date:  1984-10

5.  Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs.

Authors:  C A Hales; L Sonne; M Peterson; D Kong; M Miller; W D Watkins
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

6.  Protective activity of ketoprofen lysine salt against the pulmonary effects induced by bradykinin in guinea-pigs.

Authors:  L Daffonchio; G Rossoni; G Clavenna; C Omini; F Berti
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575

7.  Lipid composition and prostaglandin synthesis in mouse lung microsomes: alterations following the ingestion of menhaden oil.

Authors:  B R Lokesh; J E Kinsella
Journal:  Lipids       Date:  1985-12       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.